Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer. (Q53072832)
Jump to navigation
Jump to search
scientific article published in April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer. |
scientific article published in April 2014 |
Statements
Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer. (English)
Katrina N Slaughter
Theresa Thai
Shayla Penaroza
Elangovan Thavathiru
Kai Ding
Tina Nelson
D Scott McMeekin
1 April 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference